Anti-Cancer Activity of a Novel Small Molecule Compound That Simultaneously Activates p53 and Inhibits NF-κB Signaling

• Sun Gwan Hwang,

  Affiliations Drug Development Center, SK Biopharmaceuticals Co., Ltd., Daejeon, Korea, Laboratory of G Protein Coupled Receptors, Graduate School of Medicine Korea University, Seoul, Korea

  ⨯
• Jinah Park,

  Affiliation Korean Bioinformation Center, KRIBB, Daejeon, Korea

  ⨯
• Joo Young Park,

  Affiliation Drug Development Center, SK Biopharmaceuticals Co., Ltd., Daejeon, Korea

  ⨯
• Cheol Hyoung Park,

  Affiliation Drug Development Center, SK Biopharmaceuticals Co., Ltd., Daejeon, Korea

  ⨯
• Ki-Ho Lee,

  Affiliation Drug Development Center, SK Biopharmaceuticals Co., Ltd., Daejeon, Korea

  ⨯
• Jeong Woo Cho,

  Affiliation Drug Development Center, SK Biopharmaceuticals Co., Ltd., Daejeon, Korea

  ⨯
• Jong-Ik Hwang,

  Affiliation Laboratory of G Protein Coupled Receptors, Graduate School of Medicine Korea University, Seoul, Korea

  ⨯
• Jae Young Seong

  * E-mail: jyseong@korea.ac.kr

  Affiliation Laboratory of G Protein Coupled Receptors, Graduate School of Medicine Korea University, Seoul, Korea

  ⨯